Immix Biopharma, Inc. IMMX Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

Johnson & JohnsonJNJ

1.1×+0.1×

AbbVieABBV

0.8×0.0×

Nuvectis Pharma, Inc.NVCT

2.3×-1.0×

RegenxbioRGNX

2.9×-0.3×

Artiva Biotherapeutics, Inc.ARTV

24.2×+10.3×

FAQ

What is Immix Biopharma, Inc.'s current ratio?

Immix Biopharma, Inc. (IMMX) reported current ratio of 8.8× in Q1 2026.

How has Immix Biopharma, Inc.'s current ratio changed year-over-year?

Immix Biopharma, Inc.'s current ratio increased by 385.6% year-over-year, from 1.8× to 8.8×.

What is the long-term trend for Immix Biopharma, Inc.'s current ratio?

Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s current ratio has grown at a 150.8% compound annual growth rate (CAGR), from 0.1× to 10×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.